Blood News and Research

RSS

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

For pregnant women with type 1 diabetes, a technology giving insulin doses, as informed by a smartphone algorithm, helps them better manage their blood sugars compared with traditional insulin pumps or multiple daily injections, according to a new randomized trial published in The New England Journal of Medicine (NEJM) and presented at the European Association for the Study of Diabetes (EASD) meeting in Hamburg (2-6 October).

5 Oct 2023

Researchers identify new potential treatments for children with rare genetic conditions of blood vessels

A research team at the Francis Crick Institute and Great Ormond Street Hospital (GOSH)/UCL Great Ormond Street Institute of Child Health have identified new potential treatments for children with rare genetic conditions of blood vessels, which cause severe, lifelong, and disabling symptoms like seizures and impaired development.

5 Oct 2023

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.

5 Oct 2023

New calculation may help identify aortic stenosis patients at higher risk of death

Mayo Clinic researchers have developed a calculation that can help identify moderate aortic stenosis patients at higher risk of dying from the condition.

5 Oct 2023

New insights into how neutrophils fight Candida albicans infection

Umeå University researchers, Sweden, unveil how the most common white blood cells, neutrophils, counter Candida albicans toxin stopping its tracks.

5 Oct 2023

Genetics linked to placental growth and risk of preeclampsia

New research has shed light on how genetics influences the growth of the placenta, revealing a link to risk of disease in the mother.

5 Oct 2023

Organoid medicine reveals promising covid-19 treatment target

When the new SARS-CoV-2 virus began killing thousands of people every week, physicians and scientists around the globe raced to learn why the new pathogen was so deadly.

5 Oct 2023

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

Automated insulin delivery should be rolled out to pregnant women with type 1 diabetes - according to researchers at the University of East Anglia.

5 Oct 2023

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Challenges associated with the development and design of neoantigen cancer vaccines.

5 Oct 2023

KFF Health News' 'What the Health?': An encore: 3 HHS secretaries reveal what the job is really like

This week, while KFF Health News' "What the Health?" takes a break, here’s an encore of a favorite episode this year: Host and chief Washington correspondent Julie Rovner leads a rare conversation with the current and two former secretaries of Health and Human Services.

5 Oct 2023

Remote ischemic conditioning for acute stroke

The effect of remote ischemic conditioning (RIC) on functional outcomes in patients with acute stroke.

5 Oct 2023

New device simulates human diseases in multiple organs

Imagine a device smaller than a toddler's shoebox that can simulate any human disease in multiple organs or test new drugs without ever entering - or harming - the body.

4 Oct 2023

Study confirms accuracy of Vienna Prediction Model for venous thromboembolism

A prediction model can be used to identify people affected by venous thromboembolism who have only a low risk of recurrence and may not require long-term blood thinning.

4 Oct 2023

Newly identified protein markers could signal early development of metastatic lung cancer

Researchers at Mays Cancer Center at The University of Texas Health Science at San Antonio (UT Health San Antonio) have identified protein markers that could signal for early development of metastatic lung cancer, providing possibilities for new treatment.

4 Oct 2023

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Tirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to treatment, as it is at treating T2D diagnosed later in life, new research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found.

4 Oct 2023

Organ-on-chip model sheds light on lymphedema

In a new PNAS study co-authored by Boston University biomedical engineer Dr. Chris Chen, researchers say they're getting closer to understanding the mysteries of lymphedema - a condition characterized by the buildup of fluid in the body due to a malfunctioning lymphatic system.

4 Oct 2023

Study finds cluster of common conditions may signal early onset of type 2 diabetes

New research presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), reveals a marked increase in several common conditions in the years leading up to, and immediately prior to, type 2 diabetes diagnosis, suggesting considerably earlier diagnosis might be possible in some patients.

4 Oct 2023

How vitamin D and genetics shape early brain development

The study examined how vitamin D levels and vitamin D binding protein genotypes in both pregnant mothers and their children aged 3-5, impact early childhood neurodevelopment. Findings suggest that higher vitamin D concentrations in children were associated with better neurodevelopmental scores, with additional influences from sociodemographic factors and certain genetic variations.

4 Oct 2023

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.

4 Oct 2023

The adipose tissue dysfunction behind metabolically healthy obesity

A session at this year's Annual Meeting of the European Association for the Study of Diabetes will explore the latest data on the concept of metabolically healthy obesity (MHO) – more commonly known by the public as 'fat but fit'.

4 Oct 2023

Blood News and Research

New technology helps pregnant women with type 1 diabetes to better manage blood sugar levels

Researchers identify new potential treatments for children with rare genetic conditions of blood vessels

Blood test for pan-cancer biomarker could revolutionize early cancer detection

New calculation may help identify aortic stenosis patients at higher risk of death

New insights into how neutrophils fight Candida albicans infection

Genetics linked to placental growth and risk of preeclampsia

Organoid medicine reveals promising covid-19 treatment target

Automated insulin delivery could be a game-changer for pregnant women with type 1 diabetes

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

KFF Health News' 'What the Health?': An encore: 3 HHS secretaries reveal what the job is really like

Remote ischemic conditioning for acute stroke

New device simulates human diseases in multiple organs

Study confirms accuracy of Vienna Prediction Model for venous thromboembolism

Newly identified protein markers could signal early development of metastatic lung cancer

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Organ-on-chip model sheds light on lymphedema

Study finds cluster of common conditions may signal early onset of type 2 diabetes

How vitamin D and genetics shape early brain development

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

The adipose tissue dysfunction behind metabolically healthy obesity

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News